(Q39842380)

15 September 2017

1 reference

title

Hepatic first-pass metabolism in liver disease (English)

1 reference

15 September 2017

Hepatic First-pass Metabolism in Liver Disease (English)

1 reference

10.2165/00003088-197904060-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-197904060-00002

19 April 2023

1 reference

10.2165/00003088-197904060-00002

https://api.crossref.org/works/10.2165/00003088-197904060-00002

19 April 2023

1

T. F. Blaschke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391462

19 April 2023

author name string

P. C. Rubin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391462

19 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=391462

19 April 2023

publication date

1 November 1979

1 reference

Clinical Pharmacokinetics

15 September 2017

published in

1 reference

15 September 2017

volume

4

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

423-432

1 reference

Influence of congestive heart failure on prazosin kinetics

15 September 2017

cites work

1 reference

12 December 2020

Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration

1 reference

12 December 2020

Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol

1 reference

12 December 2020

Effect of portacaval shunt on the disposition of drugs with and without first-pass effect

1 reference

12 December 2020

Effect of phenobarbitone on the disposition of lignocaine and warfarin in the dog

1 reference

12 December 2020

Elimination of paracetamol in chronic liver disease

1 reference

12 December 2020

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration

1 reference

12 December 2020

Pulmonary Disease and Drug Kinetics

1 reference

12 December 2020

The hepatic artery: Subservient to hepatic metabolism or guardian of normal hepatic clearance rates of humoral substances

1 reference

12 December 2020

Clinical pharmacokinetics of hydrallazine

1 reference

12 December 2020

Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis

1 reference

12 December 2020

Pharmacokinetics in patients with cardiac failure

1 reference

12 December 2020

Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Route of Administration and Drug Disposition

1 reference

12 December 2020

Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow

1 reference

12 December 2020

Pharmacokinetics of propranolol in normal healthy volunteers

1 reference

12 December 2020

Decreased first-pass metabolism of labetalol in chronic liver disease

1 reference

12 December 2020

The disposition of propranolol. I. Elimination during oral absorption in man

1 reference

12 December 2020

Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole

1 reference

12 December 2020

Mechanism for reduced drug clearance in patients with cirrhosis

1 reference

12 December 2020

Kinetics of chlormethiazole in patients with alcohol withdrawal manifestations

1 reference

12 December 2020

Protein Binding and Kinetics of Drugs in Liver Diseases

1 reference

12 December 2020

Propranolol disposition in chronic liver disease: a physiological approach

1 reference

12 December 2020

Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease

1 reference

12 December 2020

Clinical Pharmacokinetics of Propranolol

1 reference

12 December 2020

Breath tests in gastroenterology

1 reference

12 December 2020

Kidney disease and drug metabolism

1 reference

12 December 2020

Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]

1 reference

12 December 2020

Altered Hepatic Blood Flow and Drug Disposition1

1 reference

12 December 2020

10.2165/00003088-197904060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

15 September 2017

1042402993

0 references

1 reference